ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS ESCI Q3Scopus Q2SCImago #6,517Gold OA

Journal of Clinical Tuberculosis and Other Mycobacterial Diseases

Identifier (ISSN):2405-5794(Print)
•
Publisher:Elsevier
Clarivate JCR Index Advisory: Active (ESCI)
Clarivate IF (2026)
2.3↑ +0.3
Journal Impact Factor
IF Trend↓
WoS Quartile
Q3
WoS ESCIJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2023–2026)

Clarivate IF trend for Journal of Clinical Tuberculosis and Other Mycobacterial Diseases

WoS Q3
1223220231.92024220252.32026
Annual Impact Factor Metric
Current (2026):2.3
Scopus SJR & RankScopus Q2
0.832
#6,517

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
31

31 papers with at least that number of citations each

WoS: ESCIQ3
Self-Citation Rate0%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessGold OA
77articles/year
100% Gold OA•85.71% Original Research

Aims & Scope

Journal of Clinical Tuberculosis and Mycobacterial Diseases aims to provide a forum for clinically relevant articles on all aspects of tuberculosis and other mycobacterial infections, including (but not limited to) epidemiology, clinical investigation, transmission, diagnosis, treatment, drug-resistance and public policy, and encourages the submission of clinical studies, thematic reviews and case reports. Journal of Clinical Tuberculosis and Mycobacterial Diseases is an Open Access publication.

Topics Covered (Recognized by AI)
MedicinePathology91.2%Tuberculosis86.5%Internal medicine75.3%Biology68.5%Genetics43.2%Surgery42.1%Mycobacterium tuberculosis36.2%Chemistry33.2%Mathematics31.2%Biochemistry29.7%Immunology27.9%Microbiology25.9%Statistics25.3%Psychology23.8%Political science21.5%Geology20.6%Law20.6%Family medicine20.3%

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRESCI2026

INFECTIOUS DISEASES

Q3
Rank87/141
IndexESCI
JCRESCI2026

MICROBIOLOGY

Q3
Rank124/167
IndexESCI
JCRESCI2026

RESPIRATORY SYSTEM

Q3
Rank60/107
IndexESCI
JCIESCI2026

INFECTIOUS DISEASES

Q3
Rank89/141
IndexESCI
JCIESCI2026

MICROBIOLOGY

Q3
Rank115/167
IndexESCI
JCIESCI2026

RESPIRATORY SYSTEM

Q3
Rank67/107
IndexESCI

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF2.3
Articles / Year64
Total Citations8
2025
IF2
Articles / Year68
Total Citations166
2024
IF1.9
Articles / Year90
Total Citations339
2023
IF2
Articles / Year69
Total Citations596
2022
IF—
Articles / Year50
Total Citations573

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #6,517Scopus Q2SCImago Profile
Scopus Coverage:2015-2026
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q2
0.832

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
2.32

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,103 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations525
3-Year Documents201
Citable Documents198

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate50.4%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Infectious DiseasesQ2
Microbiology (medical)Q2
Pulmonary and Respiratory MedicineQ2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
4区INFECTIOUS DISEASES
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Journal of Clinical Tuberculosis and Other Mycobacterial Diseases (ISSN: 2405-5794) is a peer-reviewed international scholarly journal in the field of Medicine, published by Elsevier in United Kingdom. The periodical holds a Journal Impact Factor (JIF) of 2.30, ranking in quartile Q3 of Web of Science (ESCI), a Scopus SJR indicator of 0.832 (Q2), an H-index of 31.

The journal enforces rigorous peer evaluation with an annual output of approximately 77 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $3,103 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Gold OA
Publisher
Elsevier
Publication Language
English
Frequency
Periodic
Indexing & Databases
ESCIScopusDOAJPubMed

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 2454bee0-9e83-43ad-a71e-25bddf3d2d0d
Database Updated: 2026-10-16